Evaluations of Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Ataxia-Teleangiectasia Patients
Phase of Trial: Phase II
Latest Information Update: 19 May 2015
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ataxia telangiectasia
- Focus Therapeutic Use
- Acronyms IEDAT01
- 19 May 2015 According to an EryDel media release, results of this 2 year extension study were published in Neurology Neuroimmunology & Neuroinflammation.
- 19 May 2015 Results published in an EryDel media release.
- 05 Feb 2013 Additional identifiers (EudraCT2010-022315-19; IEDAT-ERY01-2010) added.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History